After the war, the alliance between the United States and the Soviet Union collapsed instantly, but Japan became an economic power with the support of the United States. Regardless of economic, scientific, social and other aspects, Japan has strong strengths. At the same time, Japan's medical test equipment and immunology research personnel are also in the world's leading position. Under such circumstances, why has Japan announced its "giving up" early in vaccine research?
The sudden COVID-19 pandemic has plunged overseas countries into endless suffering, and people have become increasingly eager for the development of a new crown vaccine. Some countries are scrambling to start research on the new crown virus. Now China and Russia have successively heard good news. The popularization of vaccines is just around the corner, but Japan seems to be unable to do so.
According to a report from the Global Times on September 16, Japan currently has fewer than five research teams on the new crown vaccine, and only one team has successfully entered the first phase of the trial. There are very few reports about the new crown vaccine in Japan. This is confusing, because Japan's achievements in various fields have been obvious to all. Even the research on precision instruments and industrial materials has reached a level beyond which other countries can't get involved. Why has it been this time?" Crane tail".
In this regard, the Global Times gives several analyses.
1. Japan did not seize the critical opportunity to start
In the early stage of the outbreak, Japan’s response was relatively slow and there was no immediate collection of virus attributes. When the new coronavirus spreads to a certain extent, Japan will focus on testing, screening, isolation, and prevention and control. So much so that Japan fell behind and couldn't keep up. When Slow God wanted to collect virus specimens, changes had already taken place.
2. The Japanese government does not support enterprises enough
Many companies and scientific research units in Japan wanted to start vaccine research and development at an early stage, but without the support of national policies, some very direct pathogen data could not be collected. Because of the inherent thinking of the Japanese, they believe that only the data studied by their own hands are true, so they gave up the road of importing from other countries.
3. Japan's economy is strained
The research and development of the new crown vaccine cannot see results in a short period of time, and various protections during the epidemic have made Japan's finances tight. It is also a considerable expense to increase the research on the new crown vaccine.
Faced with such an embarrassing problem, it is not easy for Japan to become a leader in the research of new crown vaccines. It is even more difficult to take the lead in completing vaccine research under the conditions of lack of financial and human resources. In this way, it is reasonable for Japan to take the lead in raising the white flag in this battle.